Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 after the prior v3.2.0, an internal version update that does not affect user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:48:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, an administrative banner that does not affect the study details or data presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:38:45.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No meaningful changes detected in the Study Details page for NCT03276013 (Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer).
    Difference
    0.5%
    Check dated 2025-11-03T12:27:34.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:19:42.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0, indicating a new release with updated revision metadata.
    Difference
    0.1%
    Check dated 2025-09-28T10:09:05.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Updated version from v3.0.1 to v3.0.2 and removed the Back to Top element; no substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-14T00:18:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.